Amgen
AMGN
2,790 hedge funds and large institutions have $129B invested in Amgen in 2024 Q2 according to their latest regulatory filings, with 208 funds opening new positions, 1,147 increasing their positions, 1,067 reducing their positions, and 100 closing their positions.
108% more first-time investments, than exits
New positions opened: 208 | Existing positions closed: 100
58% more funds holding in top 10
Funds holding in top 10: 55 → 87 (+32)
19% more call options, than puts
Call options by funds: $2.6B | Put options by funds: $2.18B
10% more capital invested
Capital invested by funds: $117B → $129B (+$11.6B)
2% more funds holding
Funds holding: 2,722 → 2,790 (+68)
7% more repeat investments, than reductions
Existing positions increased: 1,147 | Existing positions reduced: 1,067
0.18% less ownership
Funds ownership: 77.07% → 76.89% (-0.18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$653M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$470M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$407M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$404M |
| 5 |
Goldman Sachs
New York
|
+$258M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$722M |
| 2 |
BlackRock
New York
|
-$567M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$490M |
| 4 |
JP Morgan Chase
New York
|
-$303M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$174M |
AMGN Hedge Fund Activity: Q2 2024 in Review
2,790 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2024, worth a combined $129B — up 9.9% from $117B a quarter earlier.
Buyers outnumbered sellers: 208 funds opened new AMGN positions and 100 closed out — a net gain of 108 holders — while 1,147 added to existing stakes and 1,067 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $653M. The largest seller was Barclays, cutting an estimated $722M.
- 2,790 institutional investors held Amgen (AMGN) as of Q2 2024, up from 2,722 in Q1 2024.
- Funds reported $129B of Amgen stock for Q2 2024, up 9.9% quarter-over-quarter.
- 208 funds opened new Amgen positions in Q2 2024 and 100 closed out, a net change of +108 holders.
- The largest Amgen buyer in Q2 2024 was Janus Henderson Group, an estimated $653M added.
- The largest Amgen seller in Q2 2024 was Barclays, an estimated $722M sold.
Based on aggregated 13F filings for Q2 2024.